Showing results (671-680 of 1,570) with videos related to

Sort By:
Pageof 157
American Journal of Physiology. Endocrinology and Metabolism|December 13, 2023
An extended minimal model of OGTT: estimation of α- and β-cell dysfunction, insulin resistance, and the incretin effectVijaya Subramanian, Jonatan I Bagger, Vinayak Harihar, et al.
The Journal of Clinical Endocrinology and Metabolism|June 6, 2003
Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitusT Vilsbøll, T Krarup, J Sonne, et al.
Scandinavian Journal of Gastroenterology|September 23, 1997
A double-blind placebo-controlled study on the effects of omeprazole on gut hormone secretion and gastric emptying rateL Rasmussen, N Qvist, E Oster-Jørgensen, et al.
Endocrinology|October 1, 1986
Glucagon-like peptides GLP-1 and GLP-2, predicted products of the glucagon gene, are secreted separately from pig small intestine but not pancreasC Orskov, J J Holst, S Knuhtsen, et al.
Metabolism: Clinical and Experimental|January 6, 2001
Effects of oral glucose on systemic glucose metabolism during hyperinsulinemic hypoglycemia in normal manP L Poulsen, L Orskov, T Grøfte, et al.
Scandinavian Journal of Gastroenterology|March 17, 2001
GLP-1 inhibits gastric emptying of water but does not influence plasmaE Näslund, J Bogefors, P Grybäck, et al.
Obesity Surgery|February 3, 2011
Gastric emptying of orally administered glucose solutions and incretin hormone responses are unaffected by laparoscopic adjustable gastric bandingLotte Usinger, Katrine B Hansen, Viggo B Kristiansen, et al.
Diabetes, Obesity & Metabolism|December 17, 2011
Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesityFilip K Knop, K Aaboe, T Vilsbøll, et al.
European Journal of Endocrinology|March 13, 2012
Prolonged successful therapy for hyperinsulinaemic hypoglycaemia after gastric bypass: the pathophysiological role of GLP1 and its response to a somatostatin analogueK S Myint, J R Greenfield, I S Farooqi, et al.
Diabetes Care|August 1, 1996
Glucagon-like peptide I enhances the insulinotropic effect of glibenclamide in NIDDM patients and in the perfused rat pancreasM K Gutniak, L Juntti-Berggren, P M Hellström, et al.
Pageof 157